James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, Minnesota 14642, USA.
Cancer Invest. 2010 Jan;28(1):44-5. doi: 10.3109/07357900902744544.
Cancer-associated thrombosis leads to morbidity and mortality in cancer patients. We sought to ascertain awareness of venous thromboembolism (VTE) and receptiveness to thromboprophylaxis amongst ambulatory cancer patients. In all 190 patients completed the survey over a three-week period. Of these, 100 patients (53%) reported unawareness of the increased risk of thrombosis with malignancy. Of the examined patients, 161 (86%) were willing to use oral anticoagulant for prophylaxis, and 86 (46%) were willing to perform daily anticoagulant injections. This study reveals an alarming lack of knowledge amongst patients regarding the increased risk of thrombosis. Informed patients are willing to use prophylaxis, if its effectiveness is established.
癌症相关性血栓导致癌症患者的发病率和死亡率增加。我们旨在确定门诊癌症患者对静脉血栓栓塞症（VTE）的认识程度和对血栓预防的接受程度。在三周的时间里，共有 190 名患者完成了这项调查。其中，100 名患者（53%）表示不知道恶性肿瘤会增加血栓形成的风险。在接受检查的患者中，161 名（86%）愿意使用口服抗凝剂进行预防，86 名（46%）愿意进行每日抗凝注射。这项研究表明，患者对血栓形成风险增加的认识令人担忧。如果预防措施的有效性得到证实，知情患者愿意使用预防措施。
